tell me about retatrutide π What is Retatrutide? is a next-gen, once-weekly injectable weight-loss medication from Eli Lilly that targets three hunger-related hormones (GLP-1, GIP, and glucagon) β more than existing drugs like Ozempic or Retatrutide 10 mg: vial guide
Description
What the evidence shows: 1
Summary of molecular pathways involved in cell regeneration
In today's edition of The Readout, we have: What we know about JD Vance's health investments Fertility services for Casgevy patients Inflation cooling, biotech stocks heating up Get the rundown here
99% purity verified by USA testing for GLP-1 signaling studies.
For a lot of people, GLP-1 medications like Wegovy and Ozempic have felt like a helpful tool, but for others the needles can be a little intimidating or the cost may be out of reach
Kentucky is suing prediction markets Kalshi and Polymarket as well as casino-style online game company VGW.
